Clinical trial
Efficacy and Safety of Body Weight Adjusted Nadroparin vs Standard Unfractionated Heparin for the Initial Treatment of Pulmonary Thromboembolism：a Multi-Centre, Randomised Controlled Trial in China
NCT00796692 is registered in ClinicalTrials.gov with Beijing Chao Yang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Body Weight Adjusted Nadroparin vs Standard Unfractionated Heparin for the Initial Treatment of Pulmonary Thromboembolism：a Multi-Centre, Randomised Controlled Trial in China
- Lead sponsor
- Beijing Chao Yang Hospital
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- June 30, 2002
- Completion date
- February 28, 2006
- Enrollment
- 274 (actual)
- Sites
- 39
Conditions
As the registry lists them; a condition with its own page is linked.